Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see DARK BLUE THERAPEUTICS →Already a subscriber? Sign in
Xcout Intel tracks DARK BLUE THERAPEUTICS continuously — this profile deepens as new filings, funding, people and hiring data arrive.